Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
i-Optics
1201
i-Optics
Technology
Biotechnology
breakthrough zero-dilation retinal imaging system that is ideal for the diagnosis of diabetic retinopathy, macular degeneration and glaucoma.
Suggest edits
Founded
2006
Raised
$5.8M
Follow us
Also headquartered in The Hague
Shell
Autoriteit Persoonsgegevens
FMO
Montr
Ockel Computers
Innovating Justice
ANWB
Aegon
BARBURAS
Camptoo
Companies in the same industry
Versameb
Quellis Biosciences
NBE-Therapeutics
Calidi Biotherapeutics
CN Bio Innovations
Design Therapeutics
i2o Therapeutics
SwanBio Therapeutics
Strella Biotechnology
Octant Bio
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$5,848,920
Venture capital (Series C) - 2010
Team Size
10+
Employees
I work here
Location
The Hague
,
The Netherlands
Headquarters
Explore The Hague
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when i-Optics makes some noise.